Significant Publications on Infectious Diseases Pharmacotherapy in 2025.

IF 1 Q4 PHARMACOLOGY & PHARMACY

Journal of pharmacy practice Pub Date : 2026-09-16 DOI:10.1177/08971900261486586

Vy N Quach, Khadija Thomas, Kevin Lin, Christy P Su, Hiba Al Shaikhli, Adenike Olabode, Nancy N Vuong, Nhi Nguyen

{"title":"Significant Publications on Infectious Diseases Pharmacotherapy in 2025.","authors":"Vy N Quach, Khadija Thomas, Kevin Lin, Christy P Su, Hiba Al Shaikhli, Adenike Olabode, Nancy N Vuong, Nhi Nguyen","doi":"10.1177/08971900261486586","DOIUrl":null,"url":null,"abstract":"<p><p>This review provides summarization of the most significant infectious diseases (ID) pharmacotherapy articles published in peer-reviewed literature in 2025. Members of the Houston Infectious Diseases Network (HIDN) nominated notable articles providing significant contributions to ID pharmacotherapy in 2025. Article nominations included those pertaining to general ID and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) pharmacotherapy. To aid selection of the most notable articles of 2025, a survey was created and distributed to members of the Society of Infectious Diseases Pharmacists (SIDP). A total of 32 articles were nominated by HIDN/SIDP members, 26 articles related to general ID pharmacotherapy and 6 articles focusing on HIV/AIDS. Of the 212 SIDP members who participated in the survey, there were 101 recorded votes for the top 10 general ID pharmacotherapy articles and 40 votes recorded for the top HIV/AIDS article. The most notable publications are summarized. Ongoing research continues to discover findings that enhance antimicrobial stewardship and inform best practices in infectious diseases. From over 2000 articles published on PubMed using the keywords \"infectious diseases,\" \"HIV,\" \"pharmacotherapy,\" and \"anti-infective,\" this review highlights and summarizes the most influential ID publications with aims to update clinicians on potentially practice-changing ID pharmacotherapy publications from 2025.</p>","PeriodicalId":16818,"journal":{"name":"Journal of pharmacy practice","volume":" ","pages":"8971900261486586"},"PeriodicalIF":1.0000,"publicationDate":"2026-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacy practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/08971900261486586","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

Abstract

This review provides summarization of the most significant infectious diseases (ID) pharmacotherapy articles published in peer-reviewed literature in 2025. Members of the Houston Infectious Diseases Network (HIDN) nominated notable articles providing significant contributions to ID pharmacotherapy in 2025. Article nominations included those pertaining to general ID and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) pharmacotherapy. To aid selection of the most notable articles of 2025, a survey was created and distributed to members of the Society of Infectious Diseases Pharmacists (SIDP). A total of 32 articles were nominated by HIDN/SIDP members, 26 articles related to general ID pharmacotherapy and 6 articles focusing on HIV/AIDS. Of the 212 SIDP members who participated in the survey, there were 101 recorded votes for the top 10 general ID pharmacotherapy articles and 40 votes recorded for the top HIV/AIDS article. The most notable publications are summarized. Ongoing research continues to discover findings that enhance antimicrobial stewardship and inform best practices in infectious diseases. From over 2000 articles published on PubMed using the keywords "infectious diseases," "HIV," "pharmacotherapy," and "anti-infective," this review highlights and summarizes the most influential ID publications with aims to update clinicians on potentially practice-changing ID pharmacotherapy publications from 2025.

查看原文本刊更多论文

2025年传染病药物治疗的重要出版物。

本文综述了2025年同行评议文献中发表的最重要传染病（ID）药物治疗文章。休斯顿传染病网络（HIDN）的成员在2025年提名了对传染病药物治疗做出重大贡献的著名文章。条款提名包括与一般免疫缺陷病和人体免疫缺陷病毒/后天免疫缺陷综合症（艾滋病毒/艾滋病）药物治疗有关的条款。为了帮助选出2025年最值得注意的文章，制定了一项调查，并向传染病药剂师协会（SIDP）的成员分发了这项调查。HIDN/SIDP成员共提名32篇文章，其中26篇与一般ID药物治疗有关，6篇侧重于艾滋病毒/艾滋病。在参与统计调查的212名统计小组成员中，前10名一般身份证药物治疗文章有101票记录在案，而前10名艾滋病毒/艾滋病文章有40票记录在案。总结了最著名的出版物。正在进行的研究继续发现加强抗菌剂管理和告知传染病最佳做法的发现。从PubMed上发表的2000多篇以“传染病”、“HIV”、“药物治疗”和“抗感染”为关键词的文章中，本综述突出并总结了最具影响力的ID出版物，旨在为临床医生提供2025年以后可能改变实践的ID药物治疗出版物的最新信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of pharmacy practice PHARMACOLOGY & PHARMACY-

CiteScore

3.20

自引率

7.70%

发文量

184

期刊介绍： The Journal of Pharmacy Practice offers the practicing pharmacist topical, important, and useful information to support pharmacy practice and pharmaceutical care and expand the pharmacist"s professional horizons. The journal is presented in a single-topic, scholarly review format. Guest editors are selected for expertise in the subject area, who then recruit contributors from that practice or topic area.